First "Real-World" Insights on Apremilast Treatment for Patients with Plaque Psoriasis from the LAPIS-PSO Study: An Interim Analysis

Main Article Content

Kristian Reich
Stefanie Bomas
Bernhard Korge
Maria Manasterski
Uwe Schwitchtenberg
Hannah Mentz
Kathrin Groegel


apremilast, psoriasis, plaque, clinical trial


Abstract Not Available


Disclosure: Study supported by Celgene.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)